SUPPLEMENTARY TABLE ST2 from Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study
Year: 2025
Type: supplementary-materials
Abstract: Type of Surgery and Adjuvant Therapy Received.
Authors: Clinton Yam, Miral Patel, Holly A. Hill, Ryan Sun, Roland L. Bassett, Elisabeth Kong, Senthil Damodaran, Kimberly B. Koenig, Sausan Abouharb, Sadia Saleem, Ajit K. Bisen, Rashmi K. Murthy, David L. Ramirez, Gaiane M. Rauch, Beatriz E. Adrada, Rosalind P. Candelaria, Xiaoping Wang, Elizabeth A. Mittendorf, Alastair M. Thompson, Jason B. White, Elizabeth E. Ravenberg, Alyson R. Clayborn, Qing-Qing Ding, Daniel J. Booser, Oluchi Oke, Abenaa M. Brewster, Gabriel N. Hortobagyi, Nuhad K. Ibrahim, Jennifer K. Litton, Vicente Valero, Banu K. Arun, Debu Tripathy, Jeffrey T. Chang, Ken Chen, Anil Korkut, Stacy L. Moulder, Lei Huo, Bora Lim, Naoto T. Ueno
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4409127779